Centre de Recherche Médicale de Lambaréné   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Lambarene Gabon (1981)

Organization Overview

First Clinical Trial
2014
NCT02198807
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Centre de Recherche Médicale de Lambaréné | Centre de Recherches Medicales de Lambarené | Centre de Recherches Medicales de Lambarené | Centre de Recherches Medicales de Lambarene, Lambarene, Gabon

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Ancylostomiasis (Phase 1)

Coinfection (Phase 2)

Drug-Related Side Effects and Adverse Reactions (Phase 3)

Helminthiasis (Phase 4)

Hookworm Infections (Phase 1)

Malaria (Phase 3)

Malaria, Falciparum (Phase 2)

Scabies (Phase 4)

Schistosomiasis (Phase 3)

Schistosomiasis haematobia (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 17